Susquehanna International Group, LLP Dyne Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$31.94 - $47.04 $4.49 Million - $6.61 Million
140,600 Added 578.6%
164,900 $5.92 Million
Q2 2024

Aug 15, 2024
SELL
$23.65 - $35.63 $307,450 - $463,190
-13,000 Reduced 34.85%
24,300 $857,000
Q1 2024

May 07, 2024
BUY
$13.06 - $29.18 $206,348 - $461,044
15,800 Added 73.49%
37,300 $1.06 Million
Q4 2023

Feb 14, 2024
BUY
$6.62 - $13.64 $142,330 - $293,260
21,500 New
21,500 $285,000

Others Institutions Holding DYN

# of Institutions
209
Shares Held
102M
Call Options Held
234K
Put Options Held
238K
View Full List

About Dyne Therapeutics, Inc.

DYN Quotes by TradingView
  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.24B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email